Captor Capital Corp. (CSE:CPTR, FRANKFURT:NMV, STUTTGART:NMVA, USOTC:CPTRF), (“Captor” or the “Company”), a cannabis-focused investment company, is pleased to announce the appointment of highly experienced and successful business leader, Dene Rogers, as the CEO of Captor Acquisition Corp.. Captor Acquisition Corp. is a wholly owned subsidiary, under which Captor Capital holds all of its US cannabis assets.
Mr. Rogers possesses a wealth of cannabis experience from his work with private equity firms focused on the industry. He served as the CEO of Target Australia and Sears Canada and brings with him an unparalleled depth of business, financial, strategic and operational expertise. Mr. Rogers, who holds an MSc from Oxford University and an MBA from Yale University, also held senior positions with Kmart and Radio Shack.
“We are excited to have an executive with the experience, business acumen and pedigree of Dene Rogers join Captor Acquisition Corp. as its CEO. He is a consumer-focused and strategic business leader with a long track record of success. We are confident that under Dene’s leadership, we will see tremendous growth in our U.S portfolio of cannabis assets,” said John Zorbas.
“I’m really excited to be joining the Captor team. It’s a company with a lot of unlocked potential, which was the main driver behind me joining. I look forward to bringing real value to Captor’s shareholders by growing and developing its strong portfolio of U.S cannabis investments,” said Dene Rogers.
About Captor Capital Corp.
Captor Capital Corp. is a Canadian investment firm focused on the cannabis sector listed on the Canadian Securities Exchange, the OTC, and the Frankfurt and Stuttgart stock exchanges. A vertically integrated cannabis investment company, Captor provides recreational and medical marijuana-based products to consumers via its wholly owned subsidiaries’ leading brands and dispensary locations. Through its wholly owned subsidiaries, Captor also owns and operates advanced growing facilities, which produce consistent high-quality contaminant free marijuana for its customers, as well as other high demand cannabis-based goods for consumption. The Company follows a strategy of acquiring cash flowing established companies and organizations with growth potential that require capital to scale. Captor currently has a number of revenue generating cannabis investments including the CHAI Cannabis Co. dispensaries in Santa Cruz and Monterey. The Company also owns Mellow Extracts, a highly regarded producer of cannabis extracts based in Costa Mesa, CA.
Captor Capital Corp.
NEITHER THE CANADIAN SECURITIES EXCHANGE NOR ITS REGULATIONS SERVICES PROVIDER HAVE REVIEWED OR ACCEPT RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.
This press release contains or refers to forward-looking information and is based on current expectations that involve a number of business risks and uncertainties. Factors that could cause actual results to differ materially from any forward-looking statement include, but are not limited to availability of investment opportunities, economic circumstances, market fluctuations and uncertainties, uncertainties relating to the availability and costs of financing needed in the future, changes in equity markets, inflation, changes in exchange rates, and the other risks involved in the investment industry and junior capital markets. Forward-looking statements are subject to significant risks and uncertainties, and other factors that could cause actual results to differ materially from expected results. Readers should not place undue reliance on forward-looking statements. These forward-looking statements are made as of the date hereof and the Company assumes no responsibility to update them or revise them to reflect new events or circumstances other than as required by law.
American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.
Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.
Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.
As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.
A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.
BioHarvest Sciences Inc. Unveils the Unique Polyphenolic Content of Its Upcoming Olive-Based Nutraceutical
The product will include polyphenols known to have significant health benefits.
BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.
Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.
The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).